Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?

LINKED CONTENT This article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2023-04, Vol.57 (7), p.815-816
Main Authors: Gupta, Akshita, Kedia, Saurabh, Ahuja, Vineet
Format: Article
Language:English
Subjects:
Crohn Disease - diagnosis
Crohn Disease - drug therapy
Crohn's disease
Developing Countries
Double-Blind Method
Humans
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3480-96a634351feda00be41bc727401845fea2eaacff5394cf4fb254a9a44d34ff273
container_end_page 816
container_issue 7
container_start_page 815
container_title Alimentary pharmacology & therapeutics
container_volume 57
creator Gupta, Akshita
Kedia, Saurabh
Ahuja, Vineet
description LINKED CONTENT This article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370
doi_str_mv 10.1111/apt.17410
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2786811654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2786811654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3480-96a634351feda00be41bc727401845fea2eaacff5394cf4fb254a9a44d34ff273</originalsourceid><addsrcrecordid>eNp10EtKxEAQBuBGFB0fCy8gDS7URbRf6SRuRAZfMKILXcdKUu1EkvTYnSCz8xCe0JPYOupCsDYFxcdP8ROyzdkhD3MEs_6QJ4qzJTLiUseRYFIvkxETOotEyuUaWff-iTGmEyZWyZrUGZcx4yPyMMG-R3dMe1dDQ62h0PV1PxToyqEBR_spOpjNqbGOVjU8dtbX3SMdOzvt9nw4eQSPtO7o5Ppq7N9f3yo7FA3Slym07fxkk6wYaDxufe8Ncn9-dje-jCY3F1fj00lUSpWyKNOgpZIxN1gBYwUqXpSJSBTjqYoNgkCA0phYZqo0yhQiVpCBUpVUxohEbpD9Re7M2ecBfZ-3tS-xaaBDO_hcJKlOOdexCnT3D32yg-vCd19KCBE-CupgoUpnvXdo8pmrW3DznLP8s_Y81J5_1R7sznfiULRY_cqfngM4WoCXusH5_0n56e3dIvIDrbWMgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786222480</pqid></control><display><type>article</type><title>Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?</title><source>Wiley</source><creator>Gupta, Akshita ; Kedia, Saurabh ; Ahuja, Vineet</creator><creatorcontrib>Gupta, Akshita ; Kedia, Saurabh ; Ahuja, Vineet</creatorcontrib><description>LINKED CONTENT This article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.17410</identifier><identifier>PMID: 36913501</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Crohn Disease - diagnosis ; Crohn Disease - drug therapy ; Crohn's disease ; Developing Countries ; Double-Blind Method ; Humans</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2023-04, Vol.57 (7), p.815-816</ispartof><rights>2023 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2023 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3480-96a634351feda00be41bc727401845fea2eaacff5394cf4fb254a9a44d34ff273</cites><orcidid>0000-0002-0801-789X ; 0000-0002-5758-0144 ; 0000-0002-5474-9709</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36913501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Akshita</creatorcontrib><creatorcontrib>Kedia, Saurabh</creatorcontrib><creatorcontrib>Ahuja, Vineet</creatorcontrib><title>Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>LINKED CONTENT This article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370</description><subject>Crohn Disease - diagnosis</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn's disease</subject><subject>Developing Countries</subject><subject>Double-Blind Method</subject><subject>Humans</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp10EtKxEAQBuBGFB0fCy8gDS7URbRf6SRuRAZfMKILXcdKUu1EkvTYnSCz8xCe0JPYOupCsDYFxcdP8ROyzdkhD3MEs_6QJ4qzJTLiUseRYFIvkxETOotEyuUaWff-iTGmEyZWyZrUGZcx4yPyMMG-R3dMe1dDQ62h0PV1PxToyqEBR_spOpjNqbGOVjU8dtbX3SMdOzvt9nw4eQSPtO7o5Ppq7N9f3yo7FA3Slym07fxkk6wYaDxufe8Ncn9-dje-jCY3F1fj00lUSpWyKNOgpZIxN1gBYwUqXpSJSBTjqYoNgkCA0phYZqo0yhQiVpCBUpVUxohEbpD9Re7M2ecBfZ-3tS-xaaBDO_hcJKlOOdexCnT3D32yg-vCd19KCBE-CupgoUpnvXdo8pmrW3DznLP8s_Y81J5_1R7sznfiULRY_cqfngM4WoCXusH5_0n56e3dIvIDrbWMgg</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Gupta, Akshita</creator><creator>Kedia, Saurabh</creator><creator>Ahuja, Vineet</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0801-789X</orcidid><orcidid>https://orcid.org/0000-0002-5758-0144</orcidid><orcidid>https://orcid.org/0000-0002-5474-9709</orcidid></search><sort><creationdate>202304</creationdate><title>Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?</title><author>Gupta, Akshita ; Kedia, Saurabh ; Ahuja, Vineet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3480-96a634351feda00be41bc727401845fea2eaacff5394cf4fb254a9a44d34ff273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Crohn Disease - diagnosis</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn's disease</topic><topic>Developing Countries</topic><topic>Double-Blind Method</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Akshita</creatorcontrib><creatorcontrib>Kedia, Saurabh</creatorcontrib><creatorcontrib>Ahuja, Vineet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Akshita</au><au>Kedia, Saurabh</au><au>Ahuja, Vineet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2023-04</date><risdate>2023</risdate><volume>57</volume><issue>7</issue><spage>815</spage><epage>816</epage><pages>815-816</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT This article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36913501</pmid><doi>10.1111/apt.17410</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-0801-789X</orcidid><orcidid>https://orcid.org/0000-0002-5758-0144</orcidid><orcidid>https://orcid.org/0000-0002-5474-9709</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2023-04, Vol.57 (7), p.815-816
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_2786811654
source Wiley
subjects Crohn Disease - diagnosis
Crohn Disease - drug therapy
Crohn's disease
Developing Countries
Double-Blind Method
Humans
title Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs—double whammy?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A29%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20trial%20of%20antitubercular%20therapy%20for%20diagnosing%20Crohn's%20disease%20in%20LMICs%E2%80%94double%20whammy?&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Gupta,%20Akshita&rft.date=2023-04&rft.volume=57&rft.issue=7&rft.spage=815&rft.epage=816&rft.pages=815-816&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.17410&rft_dat=%3Cproquest_cross%3E2786811654%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3480-96a634351feda00be41bc727401845fea2eaacff5394cf4fb254a9a44d34ff273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2786222480&rft_id=info:pmid/36913501&rfr_iscdi=true